Skip to content

Discontinued — last reported Q4 '22

Intangibles (Net) at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$204.66M-17.3%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$380.68M+221%
Insmed logo
InsmedINSM
$95.57M+66.5%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$121.97M-17.2%
uniQure logo
uniQureQURE
$69.99M-2.8%
Precigen logo
PrecigenPGEN
$2.86M-30.8%

Segments

By product

See full
Elevidys$19M-7.8%

Other financials

Income statement

See full
Revenue$730.8M-1.9%
Operating income-$300.4M-961%
Net income$331.0M+174%
EPS (diluted)-$4.60-1,343%

Balance sheet

See full
Cash & equivalents$464.5M+92.8%
Total debt$198.5M-3.4%
Total equity$1.5B+31.7%
Total assets$3.2B-8.3%

Cash flow

See full
Operating cash flow-$202.7M+65.3%
CapEx$2.1M-95.2%
Free cash flow-$204.8M+67.3%

Valuation

See full
Market cap$1.76B-63.1%
Enterprise value$1.5B-67.2%
P/S0.8×

Profitability

See full
Operating margin-50.8%-1.6pp
Net margin4.6%+2.4pp
FCF margin-28.7%-9.2pp

Returns & leverage

See full
Return on equity-23.6%-28.5pp
Debt / equity0.1×0.0×
Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Sarepta Therapeutics, Inc.’s 10-K, filed February 28, 2023, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s intangibles (net)?
Sarepta Therapeutics, Inc. (SRPT) reported intangibles (net) of $7.58M in Q4 2022.
How has Sarepta Therapeutics, Inc.'s intangibles (net) changed year-over-year?
Sarepta Therapeutics, Inc.'s intangibles (net) decreased by 46.8% year-over-year, from $14.24M to $7.58M.
What is the long-term trend for Sarepta Therapeutics, Inc.'s intangibles (net)?
Over 2 years (2020 to 2022), Sarepta Therapeutics, Inc.'s intangibles (net) has grown at a -25.4% compound annual growth rate (CAGR), from $13.63M to $7.58M.
What does intangibles (net) mean?
Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.